Trial design
RECRUITMENT
This study is an open-label, parallel arm, randomized controlled trial with blinded end-points, which was conducted in a medical center in Iran. Recruitment occurred between January 25, 2020 and 2 February 2020. Follow-up continued until August 5, 2021.